title: Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
abstract: Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized by the presence of short telomeres at presentation. Mutations in ten different genes, whose products are involved in the telomere maintenance pathway, have been shown to cause DC. The X-linked form is the most common form of the disease and is caused by mutations in the gene DKC1, encoding the protein dyskerin. Dyskerin is required for the assembly and stability of telomerase and is also involved in ribosomal RNA (rRNA) processing where it converts specific uridines to pseudouridine. DC is thought to result from failure to maintain tissues, like blood, that are renewed by stem cell activity, but research into pathogenic mechanisms has been hampered by the difficulty of obtaining stem cells from patients. We reasoned that induced pluripotent stem (iPS) cells from X-linked DC patients may provide information about the mechanisms involved. Here we describe the production of iPS cells from DC patients with DKC1 mutations Q31E, A353V and ΔL37. In addition we constructed "corrected" lines with a copy of the wild type dyskerin cDNA expressed from the AAVS1 safe harbor locus. We show that in iPS cells with DKC1 mutations telomere maintenance is compromised with short telomere lengths and decreased telomerase activity. The degree to which telomere lengths are affected by expression of telomerase during reprograming, or with ectopic expression of wild type dyskerin, is variable. The recurrent mutation A353V shows the most severe effect on telomere maintenance. A353V cells but not Q31E or ΔL37 cells, are refractory to correction by expression of wild type DKC1 cDNA. Because dyskerin is involved in both telomere maintenance and ribosome biogenesis it has been postulated that defective ribosome biogenesis and translation may contribute to the disease phenotype. Evidence from mouse and zebra fish models has supported the involvement of ribosome biogenesis but primary cells from human patients have so far not shown defects in pseudouridylation or ribosomal RNA processing. None of the mutant iPS cells presented here show decreased pseudouridine levels in rRNA or defective rRNA processing suggesting telomere maintenance defects account for most of the phenotype of X-linked DC. Finally gene expression analysis of the iPS cells shows that WNT signaling is significantly decreased in all mutant cells, raising the possibility that defective WNT signaling may contribute to disease pathogenesis.
authors.affiliation: Department of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
authors.forename: Bai-Wei
authors.initials: BW
authors.lastname: Gu
authors.affiliation: Department of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
authors.forename: Marisa
authors.initials: M
authors.lastname: Apicella
authors.affiliation: Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
authors.forename: Jason
authors.initials: J
authors.lastname: Mills
authors.affiliation: Department of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
authors.forename: Jian-Meng
authors.initials: JM
authors.lastname: Fan
authors.affiliation: Department of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
authors.forename: Dara A
authors.initials: DA
authors.lastname: Reeves
authors.affiliation: Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
authors.forename: Deborah
authors.initials: D
authors.lastname: French
authors.affiliation: Division of Hematology, Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Podsakoff
authors.affiliation: Department of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
authors.forename: Monica
authors.initials: M
authors.lastname: Bessler
authors.affiliation: Department of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Mason
mesh_terms: D000818:Animals; D018797:Cell Cycle Proteins / Q000235:genetics*; D002478:Cells, Cultured; D019871:Dyskeratosis Congenita / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000378:metabolism / Q000473:pathology*; D008297:Male; D051379:Mice; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics*; D012270:Ribosomes / Q000378:metabolism*; D019098:Telomerase / Q000378:metabolism; D016615:Telomere / Q000473:pathology*; D060449:Wnt Signaling Pathway
chemical_list: D018797:Cell Cycle Proteins; C112148:DKC1 protein, human; D009687:Nuclear Proteins; D019098:Telomerase